Publication | Open Access

Individualized dosimetry-based activity reduction of 90Y-DOTATOC prevents severe and rapid kidney function deterioration from peptide receptor radionuclide therapy

Dosimetry-based Activity ReductionRenal FunctionMedicineChronic Kidney DiseaseRadiopharmaceutical TherapyPharmacotherapyRenal PharmacologyPharmacologyRadiation OncologyNephrology90Y-dotatoc Prevents